Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
Noosa News17 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business16 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News16 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?